Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1DEXMEDETOMIDINE[1] Dexmedetomidine (Dexmedetomidine hydrochloride)[2] Dexmedetomidine (Dexmedetomidine),
Dexmedetomidine hydrochloride (Dexmedetomidine hydrochloride, DEXMEDETOMIDINE, DEXMEDETOMIDINE HCL, DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN SODIUM CHLORIDE) 💬
[3] ADRA2A,
ADRA2B,
ADRA2C 💬
[4] Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[15] 2, 4, 6, 21, 22, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬
2Dexmedetomidine 1[1] Dexmedetomidine (Dexmedetomidine hydrochloride)[2] Dexmedetomidine (Dexmedetomidine),
Dexmedetomidine hydrochloride (Dexmedetomidine hydrochloride, DEXMEDETOMIDINE, DEXMEDETOMIDINE HCL, DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN SODIUM CHLORIDE) 💬
[3] ADRA2A,
ADRA2B,
ADRA2C 💬
[4] Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[1] 280 💬
3Dexmedetomidine 2[1] Dexmedetomidine (Dexmedetomidine hydrochloride)[2] Dexmedetomidine (Dexmedetomidine),
Dexmedetomidine hydrochloride (Dexmedetomidine hydrochloride, DEXMEDETOMIDINE, DEXMEDETOMIDINE HCL, DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN SODIUM CHLORIDE) 💬
[3] ADRA2A,
ADRA2B,
ADRA2C 💬
[4] Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[1] 280 💬
4Dexmedetomidine 3[1] Dexmedetomidine (Dexmedetomidine hydrochloride)[2] Dexmedetomidine (Dexmedetomidine),
Dexmedetomidine hydrochloride (Dexmedetomidine hydrochloride, DEXMEDETOMIDINE, DEXMEDETOMIDINE HCL, DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN SODIUM CHLORIDE) 💬
[3] ADRA2A,
ADRA2B,
ADRA2C 💬
[4] Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[1] 280 💬
5Dexmedetomidine group[1] Dexmedetomidine (Dexmedetomidine hydrochloride)[2] Dexmedetomidine (Dexmedetomidine),
Dexmedetomidine hydrochloride (Dexmedetomidine hydrochloride, DEXMEDETOMIDINE, DEXMEDETOMIDINE HCL, DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN SODIUM CHLORIDE) 💬
[3] ADRA2A,
ADRA2B,
ADRA2C 💬
[4] Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[1] 70 💬
6Dexmedetomidine Hcl 100 Mcg/mL Inj[1] Dexmedetomidine (Dexmedetomidine hydrochloride)[2] Dexmedetomidine (Dexmedetomidine),
Dexmedetomidine hydrochloride (Dexmedetomidine hydrochloride, DEXMEDETOMIDINE, DEXMEDETOMIDINE HCL, DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN SODIUM CHLORIDE) 💬
[3] ADRA2A,
ADRA2B,
ADRA2C 💬
[4] Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[1] 215 💬
7DEXMEDETOMIDINE HYDROCHLORIDE[1] Dexmedetomidine (Dexmedetomidine hydrochloride)[2] Dexmedetomidine (Dexmedetomidine),
Dexmedetomidine hydrochloride (Dexmedetomidine hydrochloride, DEXMEDETOMIDINE, DEXMEDETOMIDINE HCL, DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN SODIUM CHLORIDE) 💬
[3] ADRA2A,
ADRA2B,
ADRA2C 💬
[4] Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[1] 70 💬
8Dexmedetomidine Hydrochloride Infusion[1] Dexmedetomidine (Dexmedetomidine hydrochloride)[2] Dexmedetomidine (Dexmedetomidine),
Dexmedetomidine hydrochloride (Dexmedetomidine hydrochloride, DEXMEDETOMIDINE, DEXMEDETOMIDINE HCL, DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN SODIUM CHLORIDE) 💬
[3] ADRA2A,
ADRA2B,
ADRA2C 💬
[4] Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[1] 6 💬
9Dexmedetomidine injection[1] Dexmedetomidine (Dexmedetomidine hydrochloride)[2] Dexmedetomidine (Dexmedetomidine),
Dexmedetomidine hydrochloride (Dexmedetomidine hydrochloride, DEXMEDETOMIDINE, DEXMEDETOMIDINE HCL, DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN SODIUM CHLORIDE) 💬
[3] ADRA2A,
ADRA2B,
ADRA2C 💬
[4] Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[1] 70 💬
10Dexmedetomidine with ropivacaine[2] Dexmedetomidine (Dexmedetomidine hydrochloride),
Ropivacaine
[4] Dexmedetomidine (Dexmedetomidine),
Dexmedetomidine hydrochloride (Dexmedetomidine hydrochloride, DEXMEDETOMIDINE, DEXMEDETOMIDINE HCL, DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN SODIUM CHLORIDE),
Ropivacaine hydrochloride ,
Ropivacaine 💬
[9] ADRA2A,
ADRA2B,
ADRA2C,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN8A,
SCN9A 💬
[9] Adrenergic signaling in cardiomyocytes, Cadherin signaling, Dopaminergic synapse, Hormone signaling, IgSF CAM signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cGMP-PKG signaling pathway 💬[1] 70 💬
11DexmedetomidineProduct Name: DexdorPharmaceutical Form: Concentrate and solvent for solution for infusionINN or Proposed INN: DEXMEDETOMIDINECAS Number: 113775-47-6Pharmaceutical form of the placebo: Concentrate and solvent for solution for infusionRoute of administration of the placebo: Intravenous use----[1] 70 💬
12Fentanyl (Low Dose) + Dexmedetomidine[2] Dexmedetomidine (Dexmedetomidine hydrochloride),
Fentanyl
[5] Fentanyl ,
Dexmedetomidine (Dexmedetomidine),
Dexmedetomidine hydrochloride (Dexmedetomidine hydrochloride, DEXMEDETOMIDINE, DEXMEDETOMIDINE HCL, DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN SODIUM CHLORIDE),
Fentanyl citrate ,
Fentanyl hydrochloride 💬
[4] ADRA2A,
ADRA2B,
ADRA2C,
OPRM1 💬
[6] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[1] 215 💬
13Scopolamine, atropine, edaravone and dexmedetomidine[4] Atropine,
Dexmedetomidine (Dexmedetomidine hydrochloride),
Edaravone,
Scopolamine
[7] Atropine ,
Scopolamine ,
Dexmedetomidine (Dexmedetomidine),
Dexmedetomidine hydrochloride (Dexmedetomidine hydrochloride, DEXMEDETOMIDINE, DEXMEDETOMIDINE HCL, DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN SODIUM CHLORIDE),
Edaravone ,
Atropine sulfate ,
Scopolamine hydrobromide 💬
[8] ADRA2A,
ADRA2B,
ADRA2C,
CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬
[16] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Hormone signaling, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 2 💬